The dose-response relationship between body mass index and the risk of incident stage ≥3 chronic kidney disease in a General Japanese Population: The ibaraki prefectural health study (IPHS)

Journal of Epidemiology

Volumn 24, Issue 6, 2014, Pages 444-451

  Tsujimoto, Takehiko ^a,b   Sairenchi, Toshimi ^b,c   Iso, Hiroyasu ^d   Irie, Fujiko ^e   Yamagishi, Kazumasa ^a,b   Watanabe, Hiroshi ^b   Tanaka, Kiyoji ^a,b   Muto, Takashi ^c   Ota, Hitoshi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Ibaraki Health Service Association   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e Ibaraki Prefectural Office   (Japan)

Author keywords

Body mass index; Chronic kidney disease; Dose response relationship; Epidemiology; Obesity

Indexed keywords

ADULT; AGED; BODY MASS; FEMALE; HUMAN; INCIDENCE; JAPAN; MALE; MIDDLE AGED; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84923837417     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140028     Document Type: Article

References (26)

1. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621-30.
2. Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392-401.
3. Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004;292: 1188-94.
4. Sasai H, Sairenchi T, Iso H, Irie F, Otaka E, Tanaka K, et al. Relationship between obesity and incident diabetes in middleaged and older Japanese adults: the Ibaraki Prefectural Health Study. Mayo Clin Proc. 2010;85:36-40.
5. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:1682-6.
6. Tsujimoto T, Sairenchi T, Iso H, Irie F, Yamagishi K, Tanaka K, et al. Impact of obesity on incident hypertension independent of weight gain among nonhypertensive Japanese: the Ibaraki Prefectural Health Study (IPHS). J Hypertens. 2012;30:1122-8.
7. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, et al. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res. 2000;8:411-21.
8. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19-33.
9. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871-80.
10. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis. 2005; 46:587-94.
11. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844-50.
12. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159-66.
13. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130:461-70.
15. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100.
16. Matsuzawa Y, Tokunaga K, Kotani K, Keno Y, Kobayashi T, Tarui S. Simple estimation of ideal body weight from body mass index with the lowest morbidity. Diabetes Res Clin Pract. 1990;10 Suppl 1:S159-64.
17. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498-509.
18. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956-62.
19. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL; PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26 Suppl 4:S21-4.
20. Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesityrelated glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44-50.
21. Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13:136-49.
22. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res. 2004;59:169-205.
23. Nickenig G, Bäumer AT, Grohè C, Kahlert S, Strehlow K, Rosenkranz S, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97:2197-201.
24. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension. 1999;33:323-8.
25. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688-708.
26. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDLcholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb. 2003;10:145-53.